Benzinga Whitehawk Therapeutics Dips Over 8% In After-Hours Trading Despite New Tempus AI Partnership
Whitehawk Therapeutics announced a multi-year partnership with Tempus AI, but its stock fell 8.81% in after-hours trading following the news. read more
Whitehawk Therapeutics announced a multi-year partnership with Tempus AI, but its stock fell 8.81% in after-hours trading following the news. read more